, Tracking Stock Market Picks
Enter Symbol:
Mast Therapeutics Inc. (MSTX) [hlAlert]

Mkt Outperform
down 78.68 %

Adventrx Pharmaceuticals, Inc. (ANX) rated Mkt Outperform with price target $9 by Rodman & Renshaw

Posted on: Thursday,  Aug 11, 2011  8:25 AM ET by Rodman & Renshaw

Rodman & Renshaw rated Mkt Outperform Mast Therapeutics Inc. (AMEX: MSTX) on 08/11/2011. Previously Rodman & Renshaw rated Mkt Outperform Mast Therapeutics Inc. (AMEX:
MSTX) on 09/10/2010., when the stock price was $1.97. Since then, Mast Therapeutics Inc. has lost 78.68% as of 08/25/2015's recent price of $0.42.
If you would have followed the previous Rodman & Renshaw's recommendation on MSTX, you would have lost 78.68% of your investment in 1810 days.

ADVENTRX Pharmaceuticals, Inc. (ADVENTRX) is a development-stage biopharmaceutical company. The Company?s business is focused on in-licensing, developing and commercializing product candidates for the treatment of cancer. Its lead product candidates, ANX-530 and ANX-514, are emulsion formulations of marketed chemotherapy drugs. ADVENTRX is focused primarily on evaluating strategic options, including the sale or exclusive license of one or more of its product candidate programs, a strategic business merger and other similar transactions. In October 2008, ADVENTRX announced that it had discontinued active work on all product candidates other than ANX-530 and ANX-514. Its wholly owned subsidiaries include SD Pharmaceuticals, Inc. (SDP) and ADVENTRX (Europe) Ltd.

Rodman & Renshaw is a full-service investment bank dedicated to providing investment banking services to companies that have significant recurring capital needs due to their growth and development strategies. We also provide research and sales and trading services to institutional investor clients that focus on such companies. Since 2003, Rodman has been a leading investment banking firm to the biotechnology sector, a capital intensive market segment, as well as a leader in the PIPE (private investment in public equity) and RD (registered direct placements) transaction markets.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
8/11/2011 8:25 AM Buy
1.09 9.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/20/2011 10:25 AM Buy
2.61 16.00
9/10/2010 9:25 AM Buy
1.97 4.50

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy